Back to Search
JEFFREY ELLERHORST, D.O.
D.O.
Family Medicine Physician
NPI: 1932237039IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
58.008028(OH)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2017
Research & Publications (20)
Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma.
PMID 19150565·J Urol·2009
8-other
Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma.
PMID 19037234·J Invest Dermatol·2009
8-other
Lack of maturation with anti-leptin receptor antibody in melanoma but not in nevi.
PMID 18836419·Mod Pathol·2009
8-other
NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma.
PMID 18668140·J Invest Dermatol·2009
8-other
Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.
PMID 18626307·Melanoma Res·2008
3-trial
Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis.
PMID 18472017·Nitric Oxide·2008
8-other
Human melanoma cells express functional receptors for thyroid-stimulating hormone.
PMID 17158770·Endocr Relat Cancer·2006
4-observational
Tumor iNOS predicts poor survival for stage III melanoma patients.
PMID 16557582·Int J Cancer·2006
8-other
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
PMID 16540661·Cancer Res·2006
8-other
Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma.
PMID 16474847·Oncogene·2006
8-other
Expression of thyrotropin-releasing hormone by human melanoma and nevi.
PMID 15328193·Clin Cancer Res·2004
8-other
HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC.
PMID 15148575·Urologe A·2004
8-other
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
PMID 15120650·Int Immunopharmacol·2004
6-review
Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.
PMID 15091196·Melanoma Res·2004
3-trial
Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy.
PMID 12771724·J Urol·2003
8-other
Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells.
PMID 12533668·Mol Cancer Ther·2003
8-other
Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.
PMID 12006516·Clin Cancer Res·2002
3-trial
Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma.
PMID 11901310·Anticancer Drugs·2002
3-trial
Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP.
PMID 11757037·Prostate·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MEMORY LN STE 200
GARRETTSVILLE, OH 44231 - Phone
- (330) 527-4852
Quick Facts
- NPI
- 1932237039
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile